Resources

  1. Ogilvie,G., Sauvageau, C., Dionne, M., McNeil, S., Krajden,M., Money, D. & Dobson, S. (2017). Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months, JAMA, April 25, 2017; 317; 16;16817. http://ovidsp.tx.ovid.com/sp-3.25.0a/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&AN=00005407-201704250-00026&NEWS=N&CSC=Y&CHANNEL=PubMed
  2. Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016;65:1405–1408. DOI: http://dx.doi.org/10.15585/mmwr.mm6549a5 https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm
  3. Tools for providers to talk with parents about HPV Immunization: https://www.cdc.gov/hpv/hcp/answering-questions.html